Journal Article Page
European UrologyVolume 58, issue 2, pages e19-e28, August 2010
Case Study of the Month
Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma
Accepted 3 March 2010, Published online 12 March 2010, pages 307 - 310
Please visit www.eu-acme.org/europeanurology to answer the following EU-ACME question online (the EU-ACME credits will be attributed automatically).
What are the options for the management of metastatic non–clear cell renal cell carcinoma?
- A. Neoadjuvant treatment with temsirolimus, sunitinib, sorafenib.
- B. Chemotherapy.
- C. Immunotherapy.
- D. Radical nephrectomy.
© 2010 European Association of Urology, Published by Elsevier B.V.
Recommend this article
Currently this article has a rating of 0. Please log in to recommend it.